title: [Transplantation of patients with cardiovascular risk].
abstract: Transplantation of patients with cardiovascular risk is becoming more frequent because of the recent changes in the characteristics of hemodialysis patients. Improvement in patient survival after transplantation has been reported in the whole cohort and is probably applicable to cardiovascular risk patients. Nevertheless, cardiovascular mortality is the leading cause of death after transplantation. Systematic screening of patients before transplantation and adapted treatment after transplantation are needed. After transplantation, immunosuppressive treatment should be tailored to the patient's profile and cardiovascular risk factors should be managed cautiously.
authors.affiliation: Service de Néphrologie-Transplantation, Hôpitaux Universitaires de Strasbourg, 1, place de l'Hôpital 67091 Strasbourg, France. sophi.caillard@chru-strasbourg.fr
authors.forename: S
authors.initials: S
authors.lastname: Caillard
authors.forename: O
authors.initials: O
authors.lastname: Inhoff
authors.forename: B
authors.initials: B
authors.lastname: Moulin
mesh_terms: D000328:Adult; D000367:Age Factors; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000601:surgery; D015897:Comorbidity; D000075202:Contraindications; D048909:Diabetes Complications; D003952:Diagnostic Imaging; D050171:Dyslipidemias / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000145:classification; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000601:surgery*; D016030:Kidney Transplantation; D008875:Middle Aged; D009204:Myocardial Revascularization; D011183:Postoperative Complications / Q000401:mortality / Q000517:prevention & control
chemical_list: D007166:Immunosuppressive Agents